Procera AVH
Natural health product licensed in Canada
- Licence holder
- Brain Research Labs, LLC
- NPN or DIN-HM
- 80043444
- Status
- Inactive licence
- Licence date
- 9 July 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Dioxyde de titane, Cellulose microcristalline, Gélatine, Talc, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Helps support brain function and/or cognitive health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are taking blood thinners, consult a health care practitioner prior to use. If you have high or low blood pressure or cardiac arrhythmia, consult a healthcare practitioner prior to use. Some people may experience anxiety, in which case, discontinue use. If you have dementia or have suffered a stroke, consult a healthcare practitioner prior to use. Consult a healthcare practitioner prior to use if you are pregnant or breastfeeding. Low incidences of seizures have been reported with oral doses in individuals with or without pre-existing seizure disorders.
Source
Official Health Canada record, licence 80043444
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.